GRADE, Grading of Recommendations Assessment, Development and Evaluation; cu-IUD, copper intrauterine device. *Adverse effects include nausea, vomiting, spotting or bleeding after treatment, early menses, and delayed menses. † Low-dose mifepristone contains less than 25 mg, whereas mid-dose mifepristone contains 25 to 50 mg. ‡ Dashes represent components not reported by the meta-analysis. Six trials demonstrated that levonorgestrel was more effective at pregnancy prevention than estradiol-levonorgestrel combination, 27 studies showed that middose mifepristone was more effective than levonorgestrel, 14 studies demonstrated low-dose mifepristone to be more effective than levonorgestrel, 25 studies showed mid-dose mifepristone to be more effective than low-dose mifepristone, 3 trials showed that single-and doubledose levonorgestrel were similar in efficacy, 2 studies suggested ulipristal acetate was more effective than levonorgestrel, and insufficient evidence was present for the Cu-IUD compared with mifepristone (Tables 1 and 2 
Commentary
Prevention of unwanted pregnancy after unprotected sexual intercourse is an important issue, with more than 40 million pregnancies ending in abortion annually worldwide. 5, 6 Emergency contraception entails the use of a medication or device after unprotected intercourse to prevent pregnancy. In regard to the agents most commonly used in the United States, levonorgestrel is available both over the counter and by prescription; conversely, ulipristal acetate (also known as UPA) is available only by prescription in the United States. Although mifepristone can be used as an abortifacient, this meta-analysis evaluates its efficacy as emergency contraception, which is its more common reason for use in China and Russia. These methods are not a substitute for pregnancy prevention through other contraception methods (eg, condoms, oral contraceptive medications). 7 However, no contraceptive method is 100% effective; emergency contraception offers a backup option for pregnancy prevention and is most effective if used immediately after unprotected intercourse. This meta-analysis included studies with reported observed pregnancies as the primary outcome. It suggests that levonorgestrel and mid-dose mifepristone (25 to 50 mg) are more effective than estradiol-levonorgestrel, with ulipristal acetate and mid-and lowdose mifepristone more effective than levonorgestrel. Mid-dose mifepristone is more effective than low-dose mifepristone. Levonorgestrel possesses fewer adverse effects than estradiollevonorgestrel. Overall, nausea and vomiting more frequently occurred in emergency contraception interventions containing demographics, with authors attempting to extract data allowing intention-to-treat analysis. Primary outcomes included observed number of pregnancies (all women) and adverse effects (overall, nausea, vomiting, spotting/bleeding after treatment, abdominal pain, and early or delayed menses). Authors assessed treatment effect with risk ratio (RR) estimates and 95% confidence intervals (CIs). Two authors independently assessed the risk of bias for each study with the Cochrane tool for assessing risk of bias for selection, performance, detection, reporting, and other bias. 1 Two reviewers independently rated overall evidence quality with the Grading of Recommendations Assessment, Development and Evaluation system and resolved disagreement with consensus. 2 Authors reviewed heterogeneity in regard to study setting, interventions, and outcomes with the c 2 test and I 2 statistic (>0.1 and >50% considered heterogeneous, respectively). 3, 4 Authors constructed summary estimates with fixed-effect models for homogenous data and randomeffects models for heterogeneous data.
estrogen, whereas progesterone and antiprogesterone methods were more commonly associated with changes in subsequent menses. This meta-analysis suggests no serious adverse effects in any of the studied emergency contraception methods.
Limitations of this meta-analysis include marked heterogeneity across included trials in regard to the emergency contraception interventions studied and study settings. Furthermore, the applicability of the study results may be challenging in some circumstances, given that many of the interventions studied are not universally available. Only 3 studies with low data quality evaluated Cu-IUD, making it difficult to derive any conclusions about its efficacy. Studies did not report influence of body mass index on emergency contraception effectiveness, although literature suggests that obesity decreases efficacy of levonorgestrel. 8, 9 Authors graded less than 15% of studies as low risk of bias for randomization. Loss to follow-up and missing outcome data are other potential sources of bias. 
